Literature DB >> 15668270

Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia.

F H van Tiel1, M M Harbers, A G Kessels, H C Schouten.   

Abstract

BACKGROUND: The purpose of this review study is to examine the accumulating evidence of safety of home care, with regard to infection-related morbidity and mortality, for patients with chemotherapy-induced cytopenia, in light of previous studies on the necessity of protective isolation (PI). PATIENTS AND METHODS: The existing literature on PI, and home care of cytopenic patients after chemotherapy, published in the English language, based on a Medline search, is reviewed.
RESULTS: The studies published so far on home care versus hospital care are all non-randomized studies and confirm that home care of cytopenic patients is safe, in terms of morbidity and mortality due to infections. On the other hand, the majority of studies on the comparison of PI with standard hospital care conclude that an infection-preventive effect of PI exists. The pooled statistics performed confirmed that such an effect of PI exists regarding the occurrence of severe infections, although no benefit to mortality has been shown.
CONCLUSIONS: Regarding home care, only the results of a prospective, randomized study of sufficient power will enable definitive conclusions to be drawn as to whether home care is equally safe as hospital-based care with PI.

Entities:  

Mesh:

Year:  2005        PMID: 15668270     DOI: 10.1093/annonc/mdi042

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  4 in total

1.  Is domestic tap water a risk for infections in neutropenic patients?

Authors:  H von Baum; M Bommer; A Forke; J Holz; P Frenz; N Wellinghausen
Journal:  Infection       Date:  2010-03-18       Impact factor: 3.553

2.  Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies.

Authors:  François Lüthi; Nadia Fucina; Nathalie Divorne; Brigitte Santos-Eggimann; Christine Currat-Zweifel; Patricia Rollier; Jean-Blaise Wasserfallen; Nicolas Ketterer; Serge Leyvraz
Journal:  Support Care Cancer       Date:  2011-03-08       Impact factor: 3.603

Review 3.  Home-deliverable antitumoral treatments in the age of COVID-19: the Portsmouth experience and a narrative review.

Authors:  Hiba Mechahougui; Harliana Yusof; Nathalie Baudoux; Shyamika Acharige; Alex Friedlaender
Journal:  Mediastinum       Date:  2022-06-25

4.  Early warning and prevention of pneumonia in acute leukemia by patient education, spirometry, and positive expiratory pressure: A randomized controlled trial.

Authors:  Tom Møller; Claus Moser; Lis Adamsen; Grith Rugaard; Mary Jarden; Tina S Bøtcher; Liza Wiedenbein; Lars Kjeldsen
Journal:  Am J Hematol       Date:  2016-02-09       Impact factor: 10.047

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.